Blauvelt A, Gordon KB, Langley RG, Branigan PJ, et al. Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2. J Invest Dermatol 2024 Jun 25:S0022-202X(24)01737.
PMID: 38936766